Research Projects
Characterization of new therapeutic targets for the treatment of hepatitis steatohepatitis: metabolic role of the splicing factor Slu7 and its regulator amphiregulin growth factor (AR)
Researcher | Principal Investigator
Hepatology: Liquid Biopsy and Carcinogenesis Research Group
Research Division
Cancer Division
Research program
Solid Tumors
Research group
Hepatology: Liquid Biopsy and Carcinogenesis
Project information
Characterization of new therapeutic targets for the treatment of hepatitis steatohepatitis: metabolic role of the splicing factor Slu7 and its regulator amphiregulin growth factor (AR) is a project of the Hepatology: Carcinogenesis (HEPACAN) research group of the Cima.
PI: Carmen Berasain
- Start date: January 1, 2014
- End date: December 31, 2016
- Funder: Instituto de Salud Carlos III
- Grant: 68.365€
- Nature of project: National
Need more information?
If you are interested in learning more about our research, please contact us.